Skip to main content
Unmet Need
Physicians
Clinical
About
News
Investors
Top Menu
Investor Relations
Investor Relations Menu
Overview
Stock Info
SEC Filings
News
Events & Presentations
Management
Corporate Governance
Investor Alerts
Aclarion, Inc. Announces Listing on Nasdaq and Pricing of $9.4 Million Initial Public Offering
More News
Aclarion Publishes 2026 Shareholder Letter from the Chairman
February 5, 2026
2026 Annual Shareholder Letter from the Chairman
February 5, 2026
Aclarion Adds High-Volume Practice, Source Healthcare, to Support Nociscan Growth and Real-World Evidence Generation
February 3, 2026
Unmet Need
Physicians
Clinical
About
News
Investors
